Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Division of Vascular Medicine, Department of Internal Medicine, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Am J Physiol Renal Physiol. 2020 Nov 1;319(5):F729-F745. doi: 10.1152/ajprenal.00407.2020. Epub 2020 Sep 28.
Chronic kidney disease (CKD) causes salt-sensitive hypertension that is often resistant to treatment and contributes to the progression of kidney injury and cardiovascular disease. A better understanding of the mechanisms contributing to salt-sensitive hypertension in CKD is essential to improve these outcomes. This review critically explores these mechanisms by focusing on how CKD affects distal nephron Na reabsorption. CKD causes glomerulotubular imbalance with reduced proximal Na reabsorption and increased distal Na delivery and reabsorption. Aldosterone secretion further contributes to distal Na reabsorption in CKD and is not only mediated by renin and K but also by metabolic acidosis, endothelin-1, and vasopressin. CKD also activates the intrarenal renin-angiotensin system, generating intratubular angiotensin II to promote distal Na reabsorption. High dietary Na intake in CKD contributes to Na retention by aldosterone-independent activation of the mineralocorticoid receptor mediated through Rac1. High dietary Na also produces an inflammatory response mediated by T helper 17 cells and cytokines increasing distal Na transport. CKD is often accompanied by proteinuria, which contains plasmin capable of activating the epithelial Na channel. Thus, CKD causes both local and systemic changes that together promote distal nephron Na reabsorption and salt-sensitive hypertension. Future studies should address remaining knowledge gaps, including the relative contribution of each mechanism, the influence of sex, differences between stages and etiologies of CKD, and the clinical relevance of experimentally identified mechanisms. Several pathways offer opportunities for intervention, including with dietary Na reduction, distal diuretics, renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists, and K or H binders.
慢性肾脏病(CKD)引起盐敏感性高血压,这种高血压通常对治疗有抗性,并且会促进肾脏损伤和心血管疾病的进展。更好地了解 CKD 中导致盐敏感性高血压的机制对于改善这些结果至关重要。本综述通过重点关注 CKD 如何影响远曲小管的 Na 重吸收,批判性地探讨了这些机制。CKD 导致肾小球-小管失衡,近端 Na 重吸收减少,远端 Na 输送和重吸收增加。醛固酮分泌进一步促进 CKD 中的远端 Na 重吸收,并且不仅通过肾素和 K 介导,还通过代谢性酸中毒、内皮素-1 和血管加压素介导。CKD 还激活肾内肾素-血管紧张素系统,生成管腔内血管紧张素 II 以促进远端 Na 重吸收。CKD 中的高膳食 Na 摄入通过非醛固酮依赖性激活通过 Rac1 介导的盐皮质激素受体,导致 Na 潴留。高膳食 Na 还会产生由 T 辅助 17 细胞和细胞因子介导的炎症反应,增加远端 Na 转运。CKD 通常伴有蛋白尿,其中包含能够激活上皮 Na 通道的纤溶酶。因此,CKD 导致局部和全身变化,共同促进远曲小管的 Na 重吸收和盐敏感性高血压。未来的研究应解决尚存的知识空白,包括每个机制的相对贡献、性别、CKD 阶段和病因之间的差异以及实验确定的机制的临床相关性。几种途径为干预提供了机会,包括减少膳食 Na、使用远端利尿剂、肾素-血管紧张素系统抑制剂、盐皮质激素受体拮抗剂以及 K 或 H 结合剂。